Regulatory PathRegulatory requirements compared

Active substance

Chloramphenicol

Open in the medicines table

SFDA Saudi Arabia — SFDA human drug list

Trade nameStrengthForm · routePackPublic priceTypeCompanyStatus
OPTICHLOR 0.5% OPTHALMIC DROP0.5 %Eye drops, solution · Ophthalmic use1 Dropper ContainerSAR 7.80Generic · PrescriptionJamjoom Pharmaceuticals Factory CompanyValid
PHENICOL 1% OPTHALMIC OINTMENT1 %Ointment · Ophthalmic use1 TubeSAR 2.25Generic · PrescriptionAmman Pharmaceutical Industries (API)Valid
RIACHOL 0.5% EYE DROP0.5 %Eye drops · Ophthalmic use1 Dropper ContainerSAR 7.00Generic · PrescriptionRIYADH PHARMAValid
RIACHOL 5% EAR DROPS5 %Ear drops · Ophthalmic use1 Dropper ContainerSAR 11.40Generic · PrescriptionRIYADH PHARMAValid
RIACHOL EYE OINT.1%1 %Eye ointment · Auricular use1 BottleSAR 10.00Generic · PrescriptionRIYADH PHARMAValid
CHLORAMEX SYRUP 160MG-5ML32 mg/mlSyrup · Oral use1 BottleSAR 13.55NCE · PrescriptionALPHARMA APSWithdrawn by MAH · Not Marketed
COLIRCUSI CHLORAMPHENICOL 0.5% DROPS0.5 %Eye drops · Ocular use1 Dropper ContainerSAR 2.55Generic · PrescriptionALCON CUSIWithdrawn by MAH · Not Marketed
FENICOL 1% OPTH.OINT.1 %Eye ointment · Ocular use1 TubeSAR 12.05Generic · PrescriptionALCON COUVREURWithdrawn by MAH · Not Marketed
ISOPTOFENICOL 0.5% EYE DROPS0.5 %Eye drops · Ocular use1 Dropper ContainerSAR 10.55Generic · PrescriptionALCON COUVREURWithdrawn by MAH · Not Marketed
KEMICETIN EYE DROPS 1%1 %Eye drops · Ocular use1 Dropper ContainerSAR 5.00NCE · PrescriptionPFIZERWithdrawn by MAH · Not Marketed
KEMICETINE OPHT OINT 1%1 %Ointment · Ocular use1 TubeSAR 3.85Generic · PrescriptionPFIZERWithdrawn by MAH · Not Marketed
MINIMS CHLORAMPHENICOL 0.5%0.5 %Eye drops, solution · Ophthalmic use20 Single Dose ContainerSAR 25.10Generic · PrescriptionCHAUVIN BAUSCH & LOMBWithdrawn by regulatory authority · Not Marketed
OFTHALMOLOSA CUSI CHLORAMPHEN.OINT 1%1 %Eye ointment · Ocular use1 TubeSAR 2.40Generic · PrescriptionALCON CUSIWithdrawn by MAH · Not Marketed
SOLUPARAXIN 1G VIAL+SOLVENT1 gInjection · Intravenous use10 AmpouleSAR 79.80NCE · PrescriptionROCHE DIAGNOSTICSWithdrawn by MAH · Not Marketed
SOLUPARAXIN 1G VIAL+SOLVENT1 gInjection · Intravenous use1 AmpouleSAR 13.05NCE · PrescriptionROCHE DIAGNOSTICSWithdrawn by MAH · Not Marketed
SPERSANICOL EYE OINT1 %Eye ointment · Ocular use1 TubeSAR 11.20NCE · PrescriptionNOVARTISWithdrawn by MAH · Not Marketed
Indications — CHI Daman Drug Formulary

MATERNAL AND CHILD HEALTHCARE- PERINATAL,INTRAPARTUM AND POSTPARTUM CARE; MUCOPURULENT CONJUCTIVITIS - GONOCOCCAL INFECTION OF THE EYE - CHLAMYDIAL CONJUNCTIVITIS

US FDA United States — FDA approvals (Drugs@FDA)

ProductStrengthForm · routeApplicantStatusFirst approved
CHLOROMYCETIN25MG/VIALfor solution · ophthalmicPARKEDALEDiscontinued1 Jun 1951
CHLOROMYCETIN1%ointment · ophthalmicPARKEDALEDiscontinued1 Jun 1951
CHLOROMYCETIN0.5%solution/drops · oticPARKEDALEDiscontinued30 Mar 1953
CHLOROMYCETINEQ 1GM BASE/VIALinjectable · injectionPARKEDALEDiscontinued20 Feb 1959
MYCHEL250MGcapsule · oralARMENPHARMDiscontinued20 Jun 1967
CHLOROPTIC0.5%solution/drops · ophthalmicALLERGANDiscontinued20 Mar 1968
CHLORAMPHENICOL1%ointment · ophthalmicALTANADiscontinued1 Oct 1968
CHLOROPTIC S.O.P.1%ointment · ophthalmicALLERGANDiscontinued21 Jul 1970
OPHTHOCHLOR0.5%solution/drops · ophthalmicPARKEDALEDiscontinued18 Nov 1970
ECONOCHLOR0.5%solution/drops · ophthalmicALCONDiscontinued26 Apr 1973
ECONOCHLOR1%ointment · ophthalmicALCONDiscontinued14 May 1974
CHLORAMPHENICOL250MGcapsule · oralIVAX SUB TEVA PHARMSDiscontinued28 Apr 1980
CHLORAMPHENICOL0.5%solution/drops · ophthalmicEPIC PHARMA LLCDiscontinued31 Aug 1981
OPTOMYCIN0.5%solution/drops · ophthalmicOPTOPICSDiscontinued31 Mar 1982
CHLORAMPHENICOL SODIUM SUCCINATEEQ 1GM BASE/VIALinjectable · injectionFRESENIUS KABI USADiscontinued25 Aug 1982
CHLORAMPHENICOL0.5%solution/drops · ophthalmicALCONDiscontinued25 Sep 1985
MYCHEL-SEQ 1GM BASE/VIALinjectable · injectionANGUSDiscontinued
CHLORAMPHENICOL SODIUM SUCCINATEEQ 1GM BASE/VIALinjectable · injectionGRUPPO LEPETITDiscontinued
CHLORAMPHENICOLEQ 1GM BASE/VIALinjectable · injectionELKINS SINNDiscontinued
CHLOROFAIR0.5%solution/drops · ophthalmicPHARMAFAIRDiscontinued
CHLOROFAIR1%ointment · ophthalmicPHARMAFAIRDiscontinued
CHLOROMYCETIN250MG/MLinjectable · injectionPARKE DAVISDiscontinued
CHLOROMYCETIN1%cream · topicalPARKE DAVISDiscontinued

Canada Canada — marketed products (Health Canada)

BrandDINStrengthForm · routeCompany
CHLOROMYCETIN SUCCINATE INJECTION003123631 G / VIALPOWDER FOR SOLUTION · INTRAVENOUSSEARCHLIGHT PHARMA INC

Prices — United States and England

SourceProduct as listedPriceUnit / packDate
NHS Drug TariffChloramphenicol 0.5% eye drops£3.4810 ml1 Oct 2026
NHS Drug TariffChloramphenicol 0.5% eye drops 0.5ml unit dose preservative free£12.1920 unit dose1 Oct 2026
NHS Drug TariffChloramphenicol 0.5% eye drops preservative free£10.1210 ml1 Oct 2026
NHS Drug TariffChloramphenicol 1% eye ointment£2.244 gram1 Oct 2026
NHS Drug TariffChloramphenicol 10% ear drops£144.2310 ml1 Oct 2026
NHS Drug TariffChloramphenicol 5% ear drops£154.9510 ml1 Oct 2026

NADAC: average price US retail pharmacies pay to buy the medicine. NHS Drug Tariff Part VIIIA: basic price reimbursed to pharmacies in England and Wales.

WHO WHO Model List of Essential Medicines (2025)

  • 6.2.1. Access group antibiotics · core
    Second choice: Bacterial meningitis
    Parenteral > General injections > IV: 1 g in vial powder for injection (sodium succinate) | Parenteral > General injections > IM: 500 mg in 2 mL ampoule oily suspension for injection
  • 5.1.6.1. Medicines for bacterial central nervous system infections · core
    Second choice: Bacterial meningitis
    Parenteral > General injections > IV: 1 g in vial powder for injection (sodium succinate) | Parenteral > General injections > IM: 500 mg in 2 mL ampoule oily suspension for injection

Combinations containing Chloramphenicol

Values as published by each source: SFDA human drug list (4-2026, as published by the Council of Health Insurance; indications from the CHI Daman Drug Formulary), Drugs@FDA, EMA medicines data, Health Canada Drug Product Database (Open Government Licence – Canada), CMS NADAC, NHS Drug Tariff Part VIIIA (NHSBSA Copyright, Open Government Licence v3.0), WHO Model List of Essential Medicines (CC BY 3.0 IGO; regrouped by active substance, not created by WHO), EMA PRAC, US FDA safety-related labeling changes and MHRA Drug Safety Update (Open Government Licence v3.0). Sources and reuse. Not a substitute for the official registers or the product information.